Crunching the numbers for REGN... Refresh in a moment for the full analysis.
REGENERON PHARMACEUTICALS, INC. (REGN)
Healthcare
Fairly Valued
healthy
$763.99
Updated: 2026-04-12
64
TradeApes Score
add
Financial Strength
80
Strong
Operating Trend
50
Mixed
Valuation
55
Mixed
Capital Allocation
65
Healthy
Risk
80
Strong
Fair Value
$512.41
DCF Upside
-32.9%
Sector Rank
#1
of 18
Key Findings
+
Net cash position — more cash on hand than total debt
See the full analysis
Quarterly financials, DCF valuation model, Watchlist, and Stock Screener.
Create Free Account
Scores and valuations are model outputs, not investment advice. TradeApes does not provide financial, tax, or investment advice.